TRADING QUOTES        CLICK ON A TAB BELOW: (Business Combination or IPO Details) to access the relevant details.  Additional info below.    PROPOSED BUSINESS COMBINATION: Cerevel Therapeutics ESTIMATED CURRENT FUNDS in TRUST: $149.6 million*CURRENT PER SHARE REDEMPTION PRICE: $10.00*ENTERPRISE VALUE: $847.4 million *SPACInsider estimate a/o 10-25-20 ARYA Sciences Acquisition Corp. II proposes to
Read More
To access this page, you must purchase a database subscription via the Subscription Store Tab or log in.